Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
renal denervation
MedTech
Medtronic, ReCor back renal denervation approach to hypertension
Two major players put forward data this week showing their devices could make a dent in hypertension.
Conor Hale
Sep 20, 2022 2:51pm
ACC: Medtronic touts 3-year renal denervation data
Apr 4, 2022 12:45pm
ReCor's renal denervation device misses blood pressure endpoint
Oct 18, 2021 10:35am
ACC: ReCor's renal denervation device cuts drug-resistant BP
May 16, 2021 10:45am
Medtronic’s renal denervation data shows better BP after 3 years
Jun 29, 2020 11:44am
Ablative Solutions bags $77M to complete hypertension device trials
Jan 4, 2019 7:30am
